Ibvilda M 1000 Tab

Tablet

Type 2 diabetes mellitus to improve blood glucose control in adults, as an adjunct to diet and exercise

Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), enhancing insulin release and reducing glucagon in a glucose-dependent manner. Metformin reduces hepatic glucose production and improves insulin sensitivity, lowering blood glucose levels.

Oral tablet. Take as prescribed, usually with meals to reduce stomach upset. Swallow whole (do not crush/chew if SR/ER). Maintain diet and exercise; monitor blood sugar regularly.

Nausea, vomiting, diarrhoea, abdominal pain, loss of appetite, headache, dizziness, upper respiratory tract infection, joint pain, low blood sugar (especially with other antidiabetics), metallic taste

Risk of lactic acidosis with metformin (seek urgent care for rapid breathing, severe weakness, muscle pain, drowsiness). Avoid/use with caution in kidney impairment; check eGFR before and during therapy. Use caution in liver disease, alcohol use, dehydration, severe infection, hypoxia, or heart failure. Withhold metformin before/after iodinated contrast procedures and major surgery as advised. Monitor for pancreatitis symptoms (severe abdominal pain), hepatitis/jaundice, and vitamin B12 deficiency with long-term use.

Alcohol (increases lactic acidosis risk), iodinated contrast media, carbonic anhydrase inhibitors (e.g., topiramate, acetazolamide), cimetidine, diuretics, corticosteroids, thyroid hormones, sympathomimetics, other antidiabetics/insulin or sulfonylureas (increased hypoglycaemia risk), ACE inhibitors (may enhance glucose-lowering)

Store below 25°C, in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Galvus Met 50/1000 Tablet, Jalra-M 50/1000 Tablet, Zomelis Met 50/1000 Tablet, Vysov-M 50/1000 Tablet, Vildamet 50/1000 Tablet